| Document |
Document Title |
|
WO/2024/002131A1 |
The present invention relates to the technical field of bioengineering, and particularly, to an engineered microorganism for efficiently expressing D-psicose 3-epimerase. The engineered microorganism comprises a constructed recombinant e...
|
|
WO/2024/000364A1 |
The present invention relates to the technical field of gene engineering and mutagenesis, and provides a corynebacterium glutamicum (C. glutamicum) efficient mutant, a recombinant bacterium construction method and a use. A highly conserv...
|
|
WO/2024/003160A1 |
The patent is related to use of one or more Pichia kluyveri strains for inhibiting or delaying growth of Saccharomyces spp. in beverages, preferably beverage with reduced alcohol content. Provided herein are also Pichia kluyveri deposite...
|
|
WO/2024/001260A1 |
Provided in the present application is a method for preparing a degradable fabric, which relates to the technical field of garment fabrics. A method for preparing a degradable fabric, which comprises the following steps: brewing tea with...
|
|
WO/2024/003950A1 |
The present invention refers to a Y-type bioreactor for microbial gas fermentation comprising an aeration chamber (2) provided with means (3) for mixing a culture broth contained within, at least a first (4) and a second gas feeding cham...
|
|
WO/2024/000620A1 |
Provided are a fusion protein and an immobilized enzyme comprising the fusion protein. The fusion protein comprises an epoxide hydrolase enzyme active moiety and a chitin protein binding moiety. By means of utilizing the specific affinit...
|
|
WO/2024/003323A1 |
The present invention relates to a method for the production of a fungal fermentation medium from brewer's spent grain (BSG) and to a fermentation medium obtainable accordingly, to a method for production of a fungal biomass by submerged...
|
|
WO/2024/005573A1 |
The present invention relates to a Bifidobacterium breve JKL2022 strain capable of mass-producing natural conjugated linoleic acid (CLA), and a method for mass-producing conjugated linoleic acid using the same. The method of the present ...
|
|
WO/2024/000368A1 |
The present invention relates to the technical field of genetic engineering, and provides recombinant Escherichia coli and a construction method therefor, and a method for synthesizing 1,5-pentanediamine. The recombinant Escherichia coli...
|
|
WO/2024/005033A1 |
Provided is a method for efficiently producing an aromatic compound by using a transformed coryneform bacterium. A method for producing an aromatic compound or a salt thereof, said method including a step for culturing a modified coryn...
|
|
WO/2024/004661A1 |
A mutant nitrile hydratase mutated from a nitrile hydratase, said nitrile hydratase being derived from Pseudonocardia thermophila and having an α subunit having 90% or more sequence identity with SEQ ID NO: 1 and a β subunit having 90%...
|
|
WO/2024/001184A1 |
A mutant of phytase APPAmut4 is provided. Compared with parents, the mutant has enhanced phytase thermostability, and an optimal mutant APPAmut9 can still retain about 70% of activity after being treated at 100 ℃ for 5 min. The provide...
|
|
WO/2024/005155A1 |
A production method of one embodiment, said production method being for producing a 4-(aminomethyl)cyclohexane-1-carboxylic acid from 1,4-bis(aminomethyl)cyclohexane, comprises using a protein that comprises an amino acid sequence having...
|
|
WO/2024/005443A1 |
The present invention relates to a novel Micrococcus flavus strain, a lysate thereof, a culture thereof, an extract from the culture, and uses thereof for improving skin condition. The strain has a skin condition-improving effect, and th...
|
|
WO/2024/003317A1 |
The present invention provides a method for increasing the ratio of epilactose:lactose and/or epilactose:lactulose in a mixture containing epilactose with other disaccharides by using a microorganism which preferentially consumes lactose...
|
|
WO/2024/006548A1 |
The present disclosure provides technologies relating to cell and/or viral particle lysis and/or nucleic acid preparation.
|
|
WO/2024/003035A1 |
The present invention relates to attenuated Piscirickettsia salmonis strains and their use as a vaccine.
|
|
WO/2024/004647A1 |
The purpose of the present invention is to provide heterotrophic microalgae having a high content of γ-aminobutyric acid, and a method for increasing the content of γ-aminobutyric acid in the heterotrophic microalgae. The present inv...
|
|
WO/2024/002331A1 |
A live bacteria strain with reduced capsules is provided. More particularly, a live bacteria strain (for example, a live Staphylococcus aureus strain) in which the production of capsules is reduced, to a vaccine against bacterial infecti...
|
|
WO/2024/003799A1 |
The present invention relates to a method for increasing the production of a nucleic acid comprising the step of limiting the total sulfur amount in the culture medium. The present invention further relates to the use of a culture medium...
|
|
WO/2024/005625A1 |
The present invention relates to a novel fermentation process using a particular strain of Kluyveromyces marxianus, referred to as KMPROTEO 1, to obtain a single-cell protein useful in the food industry. In the present description, the i...
|
|
WO/2024/006060A1 |
Solid, porous, glass-based substrate for storage and delivery of useful microorganisms are described. Materials include one or more microorganisms lyophilized on the substrate, e.g., in the form of a lyophilized biofilm. The materials ca...
|
|
WO/2024/004921A1 |
The present invention addresses the problem of providing a modified oxygenase capable of epoxidating specifically only the position-ω3 in a highly unsaturated fatty acid. The present invention relates to: a polypeptide comprising an ami...
|
|
WO/2024/005867A1 |
Fluid analyzation devices, methods, and systems are disclosed including an analyzation device comprising a sample vessel having an outer surface, a microchannel within the confines of the outer surface, a first port extending through the...
|
|
WO/2024/001593A1 |
Provided is an engineered ketoreductase polypeptide capable of preparing chiral alcohols, especially for catalyzing the reduction of ethyl 4-chloroacetoacetate to produce ethyl (R) -4-chloro-3-hydroxybutyrate. The polypeptides has high c...
|
|
WO/2024/001838A1 |
Provided are a symbiotic bacterium in humans for promoting hair growth and use thereof. Specifically, provided is use of Staphylococcus hominis in treating alopecia or promoting hair growth, skin repair and regeneration and the like. Als...
|
|
WO/2024/004139A1 |
Provided is fermented milk that contains Lacticaseibacillus paracasei bacteria and milk fat, wherein the milk fat constitutes at most 2.0 mass% of the total mass of the fermented milk.
|
|
WO/2024/001460A1 |
The present application discloses a method and carrier for biosynthesis of astaxanthin. The method comprises: realizing biosynthesis of astaxanthin in engineering bacteria capable of expressing β-carotene ketonase and β-carotene hydrox...
|
|
WO/2024/001242A1 |
A polypeptide and a use thereof are provided. The polypeptide comprises an N-terminal sequence and a C-terminal sequence, the N-terminal sequence comprising one or more repeating units, and said repeating unit comprising an amino acid se...
|
|
WO/2024/000237A1 |
Disclosed in the present invention is the use of IAA-PO1 gene in inducing primordium formation of Pleurotus ostreatus and resisting stress during the growth and development of Pleurotus ostreatus, which use belongs to the technical field...
|
|
WO/2024/005204A1 |
Provided is a novel protein, or the like, as a trispecific tribody in which antitumor effects have been augmented. The present invention relates to a fusion protein comprising a first chain and a second chain which are different from one...
|
|
WO/2023/247483A1 |
The present invention relates to a mixture of human milk oligosaccharides ("HMOs") comprising five fucosylated HMOs, as well as to an enzymatic process for making said mixture, wherein said synthesis comprises an α1-3/4-transfucosidase ...
|
|
WO/2023/249498A1 |
Disclosed are methods of epigenetic modification of microbes, including yeast and yeast starter cultures for use in fermentation of food products. The methods comprise contacting the microbe, yeast or yeast starter culture with an epigen...
|
|
WO/2023/245259A1 |
The present invention relates to plant growth promoting endophytes, preferably of plants of the Glycine genus, particularly plant growth promoting Curtobacterium sp. endophytes. The present invention also relates to seeds, plants, and pa...
|
|
WO/2023/247603A1 |
The invention generally proposes a method (1) for producing an object (2) from a vegetable material (3), comprising the following method steps: providing (4) genetically modified microorganisms (5), wherein the genetic modification (12) ...
|
|
WO/2023/248144A1 |
This invention relates to use of a strain of probiotic bacteria or derivatives thereof for increasing feed efficiency, enhancing growth and/or productivity, improving body weight or body composition, and/or increasing milk production in ...
|
|
WO/2023/247493A1 |
The use of a probiotic, particularly the Enterococcus faecium strain NCIMB 10415 which is named SF68® as probiotic active ingredient, in combination with butyric acid or a salt thereof to increase the enterocyte's health and consequentl...
|
|
WO/2023/249104A1 |
The present invention addresses the problem of providing a system for, when producing a single type of cellular product using at least two types of tissue derived from the same patient, ultimately providing said single type of cellular p...
|
|
WO/2023/247544A1 |
The present invention relates to microbial starter cultures. More specifically, a method for preparing a microbial culture such as a lactic acid bacteria (LAB) starter culture wherein at least one microbial strain such as a lactic acid b...
|
|
WO/2023/246071A1 |
The present invention provides an mreC mutant and use thereof in L-valine fermentative production. The mreC mutant is a protein obtained by mutating proline at position 150 in the wild-type mreC amino acid sequence into leucine. The intr...
|
|
WO/2023/250066A1 |
The present disclosure provides cell lysis buffers and method of use. Cell lysis buffers may comprise an aqueous solution comprising a buffering agent, a detergent, and cyanate or thiocyanate. The cell lysis buffers may be free or substa...
|
|
WO/2023/246131A1 |
The present invention provides a double-core-shell loaded microbial material as well as a preparation method therefor and the use thereof. The double-core-shell loaded microbial material is used for mineralizing heavy metals in polluted ...
|
|
WO/2023/247740A1 |
The present invention provides a method of producing amino acids by fermentation in a bioreactor, wherein the bioreactor comprises methanogenic microorganisms in a fermentation broth, the method comprising at least the step of feeding a ...
|
|
WO/2023/246505A1 |
The present invention relates to a method for inhibiting biogenic hydrogen sulfide in an oil field. A synergistic inhibition system combination agent containing Bacillus licheniformis GW1 is added into an oil field system, wherein the Ba...
|
|
WO/2023/248512A1 |
The present invention addresses the problem of providing a technology that makes it possible to remove nitrogen in wastewater with a wide range of salt concentrations. The present invention provides mixed microorganisms wherein: the mi...
|
|
WO/2023/245933A1 |
Disclosed herein are a method for efficiently producing L-homophenylalanine and a strain for producing L-homophenylalanine. According to the present invention, a new pathway for synthesizing L-homophenylalanine via enzymatic cascade reac...
|
|
WO/2023/246674A1 |
Provided is a Bifidobacterium bifidum strain ibiome001, which can significantly reduce the weight and white fat mass of high-fat feed-induced obese and diabetic mice, and improve the expression of lipolytic genes ATGL and HSL. The fastin...
|
|
WO/2023/247741A1 |
The present invention provides a method of producing amino acids by fermentation in a bioreactor, wherein the bioreactor comprises methanogenic microorganisms in a fermentation broth, the method comprising at least the step of feeding a ...
|
|
WO/2023/248690A1 |
The present disclosure provides an agent for inducing plant disease resistance, the agent being capable of effectively inducing resistance to disease in plants. An agent for inducing plant disease resistance according to the present disc...
|
|
WO/2023/247577A1 |
The present invention relates to the use of human milk oligosaccharides (HMOs) for improving the regeneration and/or viability of Lactobacillus bacteria in acidic environments. HMOs were found to increase the number of viable Lactobacill...
|
